UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Annals of oncology, 2019-07, Vol.30 (7), p.1096-1103

2019

Volltextzugriff (PDF)

Therapeutic antibodies: A new era in the treatment of respiratory diseases?

Pharmacology & therapeutics (Oxford), 2018-09, Vol.189, p.149-172

2018

Volltextzugriff (PDF)

Trends and Outcomes in the Use of Radiation Therapy in Stage I Uterine Cancer: A Study of 3139 Patients

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E290-E291

2015

Volltextzugriff (PDF)

Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii179

2018

Volltextzugriff (PDF)

Immunoregulatory gene expression and response to bevacizumab in ovarian cancer — An analysis of the cancer genome atlas

Gynecologic oncology, 2012-10, Vol.127 (1), p.S15-S15

2012

Volltextzugriff (PDF)

Genomic expression of stem cell markers in association with recurrent epithelial ovarian cancer

Gynecologic oncology, 2012-10, Vol.127 (1), p.S16-S16

2012

Volltextzugriff (PDF)

FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years

Gynecologic oncology, 2013-07, Vol.130 (1), p.e99-e99

2013

Volltextzugriff (PDF)

The potential role of immune regulation in the presentation of early vs. advanced ovarian cancer

Gynecologic oncology, 2012-10, Vol.127 (1), p.S14-S14

2012

Volltextzugriff (PDF)

Differences in tumor immune regulation between African–American and Caucasian ovarian cancer patients

Gynecologic oncology, 2012-10, Vol.127 (1), p.S14-S14

2012

Volltextzugriff (PDF)

Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S141-S141

2012

Volltextzugriff (PDF)

Immune biomarkers predictive of survival in epithelial ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S45-S46

2012

Volltextzugriff (PDF)

Immune signatures predictive of optimal cytoreduction in ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S46-S46

2012

Volltextzugriff (PDF)

Trends and progress of oncology drug development — An analysis of the FDA oncologic drug advisory committee reviews

Gynecologic oncology, 2012-10, Vol.127 (1), p.S11-S12

2012

Volltextzugriff (PDF)

Applications for oncologic drugs — Lessons from the oncologic drug advisory committee

Gynecologic oncology, 2012-10, Vol.127 (1), p.S13-S13

2012

Volltextzugriff (PDF)

Predictive model for cancer drug approval – An analysis of FDA drug submissions over the last decade

Gynecologic oncology, 2012-10, Vol.127 (1), p.S13-S14

2012

Volltextzugriff (PDF)

94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer

International journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A47-A47

2020

Volltextzugriff (PDF)

KRAS in non-small cell lung cancer

Annals of oncology, 2017-09, Vol.28, p.v599-v600

2017

Volltextzugriff (PDF)

P2.01-06 HSP72 Expression Associates with Survival in EGFR Mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S667-S667

2018

Volltextzugriff (PDF)

Progress and Trends for Cancer Drug Approval – an Analysis of FDA Advisory Committee

Annals of oncology, 2012-09, Vol.23, p.ix460

2012

Volltextzugriff (PDF)

FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10years

Gynecologic oncology, 2013-07, Vol.130 (1), p.e99

2013

Volltextzugriff (PDF)

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Annals of oncology, 2019-07, Vol.30 (7), p.1096

2019

Volltextzugriff (PDF)

A Comparative Study of Minimally Invasive Versus Open Hysterectomy for Women With Fibroid Uterus – A Nationwide Study of 65,216 Patients

Journal of minimally invasive gynecology, 2015-11, Vol.22 (6), p.S62-S62

2015

Volltextzugriff (PDF)

535PLower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Current and future therapies for advanced pancreatic cancer

Journal of surgical oncology, 2017-07, Vol.116 (1), p.25-34

2017

Volltextzugriff (PDF)

Mutation and immune profiling of metaplastic breast cancer: Correlation with survival

PloS one, 2019-11, Vol.14 (11), p.e0224726

2019

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(105)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(22)
Humans
(21)
Oncology
(16)
Hematology
(12)
Hematology, Oncology And Palliative Medicine
(12)
Obstetrics And Gynecology
(12)
Adult
(10)
Female
(8)
Middle Aged
(7)
Retrospective Studies
(7)
Aged
(6)
Immunotherapy
(6)
Aged, 80 And Over
(5)
Male
(5)
Mutation
(5)
Cancer Therapies
(4)
Immunology
(4)
Lung Cancer
(4)
Transplantation
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Therapeutic antibodies: A new era in the treatment of respiratory diseases?

Trends and Outcomes in the Use of Radiation Therapy in Stage I Uterine Cancer: A Study of 3139 Patients

Lower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC)

Immunoregulatory gene expression and response to bevacizumab in ovarian cancer — An analysis of the cancer genome atlas

Genomic expression of stem cell markers in association with recurrent epithelial ovarian cancer

FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years

The potential role of immune regulation in the presentation of early vs. advanced ovarian cancer

Differences in tumor immune regulation between African–American and Caucasian ovarian cancer patients

Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer

Immune biomarkers predictive of survival in epithelial ovarian cancer

Immune signatures predictive of optimal cytoreduction in ovarian cancer

Trends and progress of oncology drug development — An analysis of the FDA oncologic drug advisory committee reviews

Applications for oncologic drugs — Lessons from the oncologic drug advisory committee

Predictive model for cancer drug approval – An analysis of FDA drug submissions over the last decade

94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer

KRAS in non-small cell lung cancer

P2.01-06 HSP72 Expression Associates with Survival in EGFR Mutated NSCLC

Progress and Trends for Cancer Drug Approval – an Analysis of FDA Advisory Committee

FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10years

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

A Comparative Study of Minimally Invasive Versus Open Hysterectomy for Women With Fibroid Uterus – A Nationwide Study of 65,216 Patients

535PLower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC)

Current and future therapies for advanced pancreatic cancer

Mutation and immune profiling of metaplastic breast cancer: Correlation with survival

Suchergebnisse filtern